Telehealth Companies Face Existential Crisis as DEA Seeks to Pull Plug on Virtual Controlled Substance Prescribing

After years of waiting, the Drug Enforcement Administration (DEA) on Friday rolled out a new proposal to better formalize controlled substance prescriptions via telehealth. However, the proposal is not the long-awaited registration process Congress mandated for addiction treatment. If finalized, DEA’s proposed plan also moves some aspects of telehealth prescribing back to a pre-public health […]

45 State AGs Demand SAMHSA Action on Virtual Addiction Treatment

Forty-five state attorneys general have signed a letter asking the federal government to preserve COVID-era regulations for virtual addiction treatment. The letter, which was organized by the National Association of Attorneys General (NAAG), was sent to the Drug Enforcement Administration (DEA) and Substance Abuse and Mental Health Services Administration (SAMHSA). The letter specifically calls on […]

DEA Reportedly Investigating Virtual ADHD Startup Done Global

The virtual ADHD medication management company Done Global Inc., branded as Done., is reportedly under investigation by the Drug Enforcement Administration’s Diversion Control Division. DEA diversion control division agents have also made similar inquiries to Cerebral Inc., a virtual mental health company that promised speedy access to mental health prescribers, according to a Wall Street […]

Brick-and-Mortar Behavioral Health Providers Best Positioned to Weather New Telehealth Regs

Facility-based behavioral health operators may be better positioned to cope with changing telehealth regulations than their virtual-only peers. That’s because facility operators who use telehealth have the required building blocks to apply in-person treatment or telehealth as needs arise. In contrast, virtual-only companies must find other ways to partner or integrate with facility operators, according […]

Aetna Ends Cerebral’s In-Network Status, Congress Looks into Digital Health’s Compliance with Ryan Haight Act

The scrutiny around mental health startup Cerebral Inc. following the company’s meteoric rise and subsequent criticism has generated new challenges for the company. A House committee has launched a review of how the Drug Enforcement Administration (DEA) has enforced the Ryan Haight Act, which dictates how controlled substances are allowed to be prescribed via telehealth. […]

Virtual MAT Provider Bicycle Health Lands $50M in the Face of Uncertain Regulatory Environment

Boston-based Bicycle Health has raised $50 million in a Series B funding round. The virtual medication-assisted treatment (MAT) provider for opioid use disorder (OUD) appears to continue to have significant traction with investors. About a year ago, Bicycle Health raised a $27 million Series A funding round. In total, the company has raised $83 million, […]

Virtual MAT Providers Hopeful that COVID-Era Flexibilities Will Continue — But Wary About Risks

Some leaders in the virtual medication-assisted treatment (MAT) space see the opportune regulatory environment of the moment continuing post-COVID. However, virtual MAT providers were disappointed in the past by a regulatory flub at the federal level that could have secured them key flexibilities, leaving them to at least think about what might happen if current […]

Key Senators in Behavioral Health Reform Effort Call For DEA to Continue Virtual MAT Flexibility

A bipartisan duo of U.S. Senators is putting pressure on the Biden administration to make the COVID-era regulations that have freed up the use of virtual medication-assisted treatment permanent. Sens. Rob Portman (R-Ohio) and Sheldon Whitehouse (D-R.I.) called on the top executives of the Department of Health and Human Services (HHS) and Drug Enforcement Administration […]